The pharma major Cipla is the top gainer today on the Nifty index. The shares surged as much as 15 per cent to ₹589.65.
It had got the final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90 mcg from the USFDA, it said in a press release.
The drug is used in the treatment of acute events of bronchospasm.